MAREZINE Drug Patent Profile
When do Marezine patents expire, and what generic alternatives are available?
Marezine is a drug marketed by Glaxosmithkline and is included in one NDA.
The generic ingredient in MAREZINE is cyclizine lactate. There is one drug master file entry for this compound. Additional details are available on the cyclizine lactate profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for MAREZINE?
- What are the global sales for MAREZINE?
- What is Average Wholesale Price for MAREZINE?
Summary for MAREZINE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 46 |
| Patent Applications: | 4,762 |
| DailyMed Link: | MAREZINE at DailyMed |
US Patents and Regulatory Information for MAREZINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Glaxosmithkline | MAREZINE | cyclizine lactate | INJECTABLE;INJECTION | 009495-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
